CHM and diffuse large B-cell lymphoma: We did not find a significant association between expression of CHM and survival in the osteosarcoma samples, which could be due to the overall low expression level in this sample cohort, but by using DRUGSURV, we found that low expression level of CHM in two other cancer types, large diffuse B cell lymphoma and breast cancer, were significantly associated with poor survival.